| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65162-749-34 | 65162-749 | HUMAN PRESCRIPTION DRUG | Rivastigmine | Rivastigmine | PATCH | TRANSDERMAL | 20150630 | N/A | ANDA | ANDA207308 | Amneal Pharmaceuticals LLC | RIVASTIGMINE | 13.3 mg/24h | 30 PATCH in 1 CARTON (65162-749-34) / 24 h in 1 PATCH |
| 65162-825-34 | 65162-825 | HUMAN PRESCRIPTION DRUG | Rivastigmine | Rivastigmine | PATCH | TRANSDERMAL | 20150630 | N/A | ANDA | ANDA207308 | Amneal Pharmaceuticals LLC | RIVASTIGMINE | 4.6 mg/24h | 30 PATCH in 1 CARTON (65162-825-34) / 24 h in 1 PATCH |
| 65162-826-34 | 65162-826 | HUMAN PRESCRIPTION DRUG | Rivastigmine | Rivastigmine | PATCH | TRANSDERMAL | 20150630 | N/A | ANDA | ANDA207308 | Amneal Pharmaceuticals LLC | RIVASTIGMINE | 9.5 mg/24h | 30 PATCH in 1 CARTON (65162-826-34) / 24 h in 1 PATCH |